Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report
Cho HJ;Kim WR;Kim JH;Kim DH;Kim DJ;Kang H;;
Annals of coloproctology2021Vol. 37pp. -
176
hj2021annalscolonic
Abstract
With the advent of checkpoint inhibitors, it has opened up opportunities for numerous cancer patients. However, as is the case with every treatment, complications need to be weighed. Gastrointestinal adverse effects, such as diarrhea and colitis are well-known complications for checkpoint inhibitors …